<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE292nnn/GSE292992/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292992</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>MDM2 degradation overcomes feedback regulation of p53 signaling in Merkel cell carcinoma</name><description>This study explored the efficacy of MDM2 degraders, KTX-049 and KT-253, in treating Merkel cell carcinoma (MCC), an aggressive skin cancer. MCC tumors often exhibit clonal integration of Merkel cell polyomavirus, with virus-positive (MCCP) and virus-negative (MCCN) tumors showing distinct molecular profiles. MDM2, a target of the ST-MYCL- Tip60 complex in MCCP, inhibits p53-mediated tumor suppression. Our results demonstrate that KTX-049 is over 100 times more potent than the MDM2 inhibitor DS- 3032 in MCC cell lines with wild-type p53, effectively degrading MDM2 and activating the p53 response. Mathematical modeling indicates that KTX-049 collapses the p53-MDM2 feedback loop, enhancing its potency. In vivo, KT-253 induced robust and durable p53 pathway activation, producing deep tumor regressions in patient-derived xenograft models. However, the observed resistance was linked to TP53 mutations. These findings highlight the potential of MDM2 degraders as a therapeutic strategy for MCC and other tumor types with wild-type p53 and underscore the need for further investigation of resistance mechanisms and combination therapies.</description><dates><publication>2026/04/02</publication></dates><accession>GSE292992</accession><cross_references><GSM>GSM8872791</GSM><GSM>GSM8872790</GSM><GSM>GSM8872751</GSM><GSM>GSM8872795</GSM><GSM>GSM8872750</GSM><GSM>GSM8872794</GSM><GSM>GSM8872793</GSM><GSM>GSM8872792</GSM><GSM>GSM8872799</GSM><GSM>GSM8872755</GSM><GSM>GSM8872754</GSM><GSM>GSM8872798</GSM><GSM>GSM8872796</GSM><GSM>GSM8872752</GSM><GSM>GSM8872759</GSM><GSM>GSM8872758</GSM><GSM>GSM8872757</GSM><GSM>GSM8872756</GSM><GSM>GSM8872749</GSM><GSM>GSM8872762</GSM><GSM>GSM8872761</GSM><GSM>GSM8872760</GSM><GSM>GSM8872766</GSM><GSM>GSM8872765</GSM><GSM>GSM8872763</GSM><GSM>GSM8872803</GSM><GSM>GSM8872802</GSM><GSM>GSM8872769</GSM><GSM>GSM8872768</GSM><GSM>GSM8872801</GSM><GSM>GSM8872767</GSM><GSM>GSM8872800</GSM><GSM>GSM8872773</GSM><GSM>GSM8872772</GSM><GSM>GSM8872771</GSM><GSM>GSM8872770</GSM><GSM>GSM8872733</GSM><GSM>GSM8872777</GSM><GSM>GSM8872776</GSM><GSM>GSM8872774</GSM><GSM>GSM8872737</GSM><GSM>GSM8872736</GSM><GSM>GSM8872779</GSM><GSM>GSM8872735</GSM><GSM>GSM8872734</GSM><GSM>GSM8872778</GSM><GSM>GSM8872804</GSM><GSM>GSM8872780</GSM><GSM>GSM8872784</GSM><GSM>GSM8872740</GSM><GSM>GSM8872783</GSM><GSM>GSM8872782</GSM><GSM>GSM8872781</GSM><GSM>GSM8872744</GSM><GSM>GSM8872788</GSM><GSM>GSM8872742</GSM><GSM>GSM8872786</GSM><GSM>GSM8872741</GSM><GSM>GSM8872785</GSM><GSM>GSM8872748</GSM><GSM>GSM8872747</GSM><GSM>GSM8872746</GSM><GSM>GSM8872745</GSM><GSM>GSM8872789</GSM><GSM>GSM8872739</GSM><GSM>GSM8872738</GSM><GPL>34284</GPL><GSE>292992</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>